نتائج البحث 201-210 من 3649 لعملية البحث عن anti-TNF drugs
The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...
... therapy with carboplatin and vincristine. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for ...
Olatoye, M.D.. Anesthesiologist. Rochester, MN. مناطق التركيز: Pain management, Nerve block, Botox injection, Cancer treatment, Radiofrequency ablation, ...
Drugs used in chemotherapy, such as cisplatin and ... anti-HER2 therapies, such as trastuzumab ... Drugs used in chemotherapy, such as temozolomide ...
... anti-tumor activity. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia ...
The purpose of this study is to explore various biomarkers in the post-treatment tissue of patients who have responded to cancer therapy and compare it to the ...
Giving vinorelbine and VAC may kill more tumor cells. Adding maintenance therapy (vinorelbine and cyclophosphamide) after VAC therapy, with or without ...
Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy ... Collection of tissue and blood from patients with residual disease after neoadjuvant ...
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.